Show simple item record

dc.contributor.authorCoulter-Smith, S
dc.contributor.authorLambert, J S
dc.contributor.authorButler, K
dc.contributor.authorBrennan, M
dc.contributor.authorCafferkey, M
dc.date.accessioned2012-02-01T10:37:44Z
dc.date.available2012-02-01T10:37:44Z
dc.date.issued2012-02-01T10:37:44Z
dc.identifier.citationIr Med J. 2010 Jan;103(1):14-7.en_GB
dc.identifier.issn0332-3102 (Print)en_GB
dc.identifier.issn0332-3102 (Linking)en_GB
dc.identifier.pmid20222387en_GB
dc.identifier.urihttp://hdl.handle.net/10147/207712
dc.description.abstractRoutine linked HIV antenatal screening, with "opt-out", was introduced at the Rotunda in January 1998. This paper reviews the screening and subsequent pregnancy management and outcome in HIV positive women from 1998 to 2006. During this time 225 women (280 pregnancies) were HIV positive and 194 women subsequently delivered at the Rotunda, representing 233 liveborn infants. Overall anti-HIV prevalence was 0.42%, increasing from 0.06% in 1998 to 0.57% in 2006. Of 233 livebirths, 111 (48%) were delivered by spontaneous vaginal delivery (SVD). HIV treatment was started pre-pregnancy in 14 (6%) pregnancies and antenatally in 208 (90%). The vertical transmission rate in mothers receiving >4 weeks of treatment was 0%. We conclude that routine antenatal HIV screening is effective and significantly benefits the health of mother and child.
dc.language.isoengen_GB
dc.subject.mesh*Antiretroviral Therapy, Highly Activeen_GB
dc.subject.meshChi-Square Distributionen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHIV Infections/*diagnosis/*drug therapy/epidemiologyen_GB
dc.subject.meshHumansen_GB
dc.subject.meshInfectious Disease Transmission, Vertical/*prevention & controlen_GB
dc.subject.meshIreland/epidemiologyen_GB
dc.subject.meshPregnancyen_GB
dc.subject.meshPregnancy Complications, Infectious/*diagnosis/*drug therapyen_GB
dc.subject.meshPregnancy Outcomeen_GB
dc.subject.meshPrenatal Care/*methodsen_GB
dc.subject.meshRetrospective Studiesen_GB
dc.subject.meshRisk Assessmenten_GB
dc.titleHIV testing and treatment in the antenatal care setting.en_GB
dc.contributor.departmentThe Rotunda Hospital, Parnell Sq, Dublin 1.en_GB
dc.identifier.journalIrish medical journalen_GB
dc.description.provinceLeinster
html.description.abstractRoutine linked HIV antenatal screening, with "opt-out", was introduced at the Rotunda in January 1998. This paper reviews the screening and subsequent pregnancy management and outcome in HIV positive women from 1998 to 2006. During this time 225 women (280 pregnancies) were HIV positive and 194 women subsequently delivered at the Rotunda, representing 233 liveborn infants. Overall anti-HIV prevalence was 0.42%, increasing from 0.06% in 1998 to 0.57% in 2006. Of 233 livebirths, 111 (48%) were delivered by spontaneous vaginal delivery (SVD). HIV treatment was started pre-pregnancy in 14 (6%) pregnancies and antenatally in 208 (90%). The vertical transmission rate in mothers receiving >4 weeks of treatment was 0%. We conclude that routine antenatal HIV screening is effective and significantly benefits the health of mother and child.


This item appears in the following Collection(s)

Show simple item record